Application of the stockholm hierarchy to defining the quality of reference intervals and clinical decision limits

Clinical Biochemist Reviews

Volumn 33, Issue 4, 2012, Pages 141-148

  Sikaris, Ken ^a  

^a MELBOURNE PATHOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872397848     PISSN: 01598090     EISSN: 18380212     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Kallner A. Quality specifications based on the uncertainty of measurement. Scand J Clin Lab Invest 1999;59:513-6.
2. Fraser CG. General strategies to set quality specifications for reliability performance characteristics. Scand J Clin Lab Invest 1999;59:487-90.
3. Petersen PH. Quality specifications based on analysis of effects of performance on clinical decision-making. Scand J Clin Lab Invest 1999;59:517-21.
4. Klee GG, Schryver PG, Kisabeth RM. Analytic bias specifications based on the analysis of effects on performance of medical guidelines. Scand J Clin Lab Invest 1999;59:509-12.
5. Thienpont LM. Quality specifications for reference methods. Scand J Clin Lab Invest 1999;59:535-8.
6. Sandberg S, Thue G. Quality specifications derived from objective analyses based upon clinical needs. Scand J Clin Lab Invest 1999;59:531-4.
7. Ricós C, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491-500.
8. Ehrmeyer SS, Laessig RH. Effect of legislation (CLIA'88) on setting quality specifications for US laboratories. Scand J Clin Lab Invest 1999;59:563-7.
9. Westgard JO. The need for a system of quality standards for modern quality management. Scand J Clin Lab Invest 1999;59:483-6.
10. Kenny D, Fraser CG, Hyltoft Petersen P, Kallner A. Strategies to set Global Analytical Quality Specifications in Laboratory Medicine - Consensus agreement. Scand J Clin Lab Invest 1999;59:585.
11. Kaplan LA. Determination and application of desirable analytical performance goals: the ISO/TC 212 approach. Scand J Clin Lab Invest 1999;59:479-82.
12. Klee GG. Tolerance limits for short-term analytical bias and analytical imprecision derived from clinical assay specificity. Clin Chem 1993;39:1514-8.
13. Petersen PH, de Verdier CH, Groth T, Fraser CG, Blaabjerg O, Hørder M. The influence of analytical bias on diagnostic misclassifications. Clin Chim Acta 1997;260:189-206.
14. Hosogaya S, Ozaki Y. [Allowable limits of analytical error which can guarantee the reliability of reference intervals for interpretation of clinical laboratory data. (Japanese)] Rinsho Byori 2008;56:617-21.
15. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
16. Mbanya JC, Henry RR, Smith U. Presidents' statement on the WHO recommendation on HbA1c for diabetes diagnosis. Diabetes Res Clin Pract 2011;93:310-1.
17. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-11.
18. Ritchie RF, Palomaki G. Selecting clinically relevant populations for reference intervals. Clin Chem Lab Med 2004;42:702-9.
19. Clinical and Laboratory Standards Institute (CLSI). Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved guideline - Third Edition. CLSI Document C28-A3. Wayne, PA, USA: CLSI; 2008.
20. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Mårtensson A, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64:271-84.
21. Ichihara K, Itoh Y, Lam CW, Poon PM, Kim JH, Kyono H, et al. Sources of variation of commonly measured serum analytes in 6 Asian cities and consideration of common reference intervals. Clin Chem 2008;54:356-65.
22. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854-68.
23. Kohse KP, Thamm M. KiGGS-the German survey on children's health as data base for reference intervals. Clin Biochem 2011;44:479.
24. Lahti A. Are the common reference intervals truly common? Case studies on stratifying biochemical reference data by countries using two partitioning methods. Scand J Clin Lab Invest 2004;64:407-30.
25. Rustad P, Hyltoft Petersen P. Effect of analytical quality on establishing common reference intervals and their use. Scand J Clin Lab Invest 2004;64:399-406.
26. Ilcol YO, Aslan D. Use of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey. Clin Chem Lab Med 2006;44:867-76.
27. Shine B. Use of routine clinical laboratory data to define reference intervals. Ann Clin Biochem 2008;45:467-75.
28. Kairisto V, Koskinen P, Mattila K, Puikkonen J, Virtanen A, Kantola I, et al. Reference intervals for 24-h urinary normetanephrine, metanephrine, and 3-methoxy-4-hydroxymandelic acid in hypertensive patients. Clin Chem 1992;38:416-20.
29. Matsubara A, Ichihara K, Fukutani S. Determination of reference intervals for 26 commonly measured biochemical analytes with consideration of long-term within-individual variation. Clin Chem Lab Med 2008;46:691-8.
30. Arzideh F, Wosniok W, Haeckel R. Reference limits of plasma and serum creatinine concentrations from intra-laboratory data bases of several German and Italian medical centres: Comparison between direct and indirect procedures. Clin Chim Acta 2010;411:215-21.
31. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
32. Waise A, Price HC. The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism. Ann Clin Biochem 2009;46:93-8.
33. Handelsman DJ. Pharmacoepidemiology of testosterone prescribing in Australia, 1992-2010. Med J Aust 2012;196:642-5.
34. Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 2012;196:686-7.
35. Mathew TH. Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005;183:138-41.
36. Mathew TH, Johnson DW, Jones GR. Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007;187:459-63.
37. Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Doogue MP, Jose MD, et al. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust 2012;197:224-5.
38. Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Chadban SJ, Usherwood T, et al. Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement. Med J Aust 2012;197:224-5.
39. Australian Pathology Lipid Interest Group, Appleton CA, Caldwell G, McNeil A, Meerkin M, Sikaris K, et al. Recommendations for lipid testing and reporting by Australian pathology laboratories. Clin Biochem Rev 2007;28:32-45.
40. Jones G, Barker A. Standardisation of reference intervals: an Australasian view. Clin Biochem Rev 2007;28:169-73.
41. Reed M. The New Zealand approach to harmonised reference intervals. Clin Biochem Rev 2012;33:115-8.
42. Taylor N, Meerkin M, Sikaris KA, McNeil A, Garcia Webb P, Guerin M. Patient data defined LFT reference intervals. Clin Biochem Rev 2001;22:89.
43. Sikaris KA, Kanowski D, Caldwell G, Sack S, Flatman R. Consensus network reference intervals. Clin Biochem Rev 2006;27(Suppl.):S34.
44. Sikaris KA, Lu Z, Kanowski D, Price L, Flatman R, Caldwell G, et al. Defining Sonic network reference intervals for children. Clin Biochem Rev 2009;30:S20.
45. Sikaris KA, Lu Z, Kanowski D, Price L, Flatman R, Caldwell G, et al. Defining Sonic network reference intervals for pregnancy. Clin Biochem Rev 2009;30:S20.
46. Compton PJ, Stuart MC, Lazarus L. Error in laboratory reference limits as shown in a collaborative quality-assurance program. Clin Chem 1986;32:845-9.
47. Zardo L, Secchiero S, Sciacovelli L, Bonvicini P, Plebani M. Reference intervals: are interlaboratory differences appropriate? Clin Chem Lab Med 1999;37:1131-3.
48. Friedberg RC, Souers R, Wagar EA, Stankovic AK, Valenstein PN; College of American Pathologists. The origin of reference intervals. Arch Pathol Lab Med 2007;131:348-57.
49. Berg J. The approach to pathology harmony in the UK. Clin Biochem Rev 2012;33:89-93.
50. Berg J, Lane V. Pathology Harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory. Ann Clin Biochem 2011;48:195-7.
51. Sciacovelli L, Zardo L, Secchiero S, Zaninotto M, Plebani M. Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness. Clin Chim Acta 2003;333:209-19.
52. Partin AW, Criley SR, Subong EN, Zincke H, Walsh PC, Oesterling JE. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: a pathological analysis. J Urol 1996;155:1336-9.
53. Apple FS, Morrow D, Zaugg C, Hickey D, Zaharik M, Blackwood JJ, et al. The challenges and concerns companies face pertaining to the US Food and Drug Administration 510(k) process for cardiac biomarkers. Clin Chem 2012;58:31-8.
54. Soldin SJ, Wong EC, Brugnara C, Soldin OP (Editors). Pediatric Reference Intervals. 7th Edition. Washington DC, USA: AACC Press; 2011.
55. Gronowski AM (Editor). Handbook of Clinical Laboratory Testing During Pregnancy. Totowa NJ, USA: Humana Press; 2004.
56. Haeckel R, Wosniok W. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art. Clin Chem Lab Med 2011;49:623-35.
57. Petersen PH, Sandberg S, Fraser CG. Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus? Clin Chem Lab Med 2011;49:637-40.
58. Petersen PH, Jensen EA, Brandslund I. Analytical performance, reference values and decision limits. A need to differentiate between reference intervals and decision limits and to define analytical quality specifications. Clin Chem Lab Med 2011;50:819-31